NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed
ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development The investment is part of ImpriMed's $10 million Series A2 bridge round as the company advances U.S....
NAVER D2SF Invests in AI-Powered Autonomous Driving Startup "whereable.ai"
- Plug-and-play autonomous driving solution enabling immediate operation in any environment - Founded by the cofounders of ThorDrive, an autonomous vehicle startup… Secured the Incheon Airport project within just 4 months after its founding - NAVER...